Clinical Trial Update: Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results comparing an unnamed monoclonal antibody to zoledronic acid in women with breast cancer and bone metastases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hypercalcemia of Malignancy

Drugs mentioned

• Unspecified monoclonal antibody
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Breast Cancer, Hypercalcemia of Malignancy | Phase 1, Phase 2 | Status: COMPLETED